Associated Feature — Skin Thickening
Skin thickening is an associated feature in the BI-RADS v2025 MRI lexicon defined as skin measuring > 2 mm in thickness. Normal breast skin measures approximately 0.5–2 mm, with physiologic variation at the inframammary fold and periareolar region where skin is normally thicker. Skin thickening may be focal (localized to a region) or diffuse (involving most or all of the breast).
Imaging Appearance
T1-Weighted (Pre-Contrast)
- Thickened skin appears as a band of intermediate signal along the breast surface
- Best assessed on non-fat-suppressed T1W sequences where skin-fat interface is well delineated
- Comparison with the contralateral breast is essential for subtle cases
T2-Weighted / STIR
- Edematous skin thickening shows T2 hyperintensity within the dermis
- Associated subcutaneous edema may appear as reticular T2-bright stranding in the premammary fat
- T2 signal helps distinguish edematous (bright) from fibrotic (dark) thickening
Post-Contrast (DCE-MRI)
- Skin thickening without enhancement: more likely benign or post-treatment
- Skin thickening with enhancement: raises concern for inflammatory breast cancer or direct tumor invasion
- Enhancement pattern matters: diffuse dermal enhancement is more worrisome than focal post-surgical enhancement
DWI
- Restricted diffusion within thickened skin may indicate tumor infiltration of the dermis
- Low ADC values in the setting of skin thickening should prompt further evaluation for inflammatory carcinoma
Etiologies
Malignant
- Inflammatory breast cancer (IBC): diffuse skin thickening with dermal enhancement, often with peau d’orange clinically
- Direct tumor invasion: focal skin thickening adjacent to a superficial mass
- Dermal lymphatic invasion: tumor emboli in dermal lymphatics causing edema and thickening
- Locally advanced breast cancer with skin involvement
Benign
- Prior surgery: focal thickening at or near the surgical scar
- Radiation therapy: typically diffuse, develops weeks to months post-treatment, may persist for years
- Mastitis / abscess: focal or regional, with clinical signs of infection
- Systemic edema: CHF, renal failure, hypoalbuminemia — typically bilateral and symmetric
- Axillary lymph node obstruction: ipsilateral diffuse thickening from impaired lymphatic drainage
- Trauma / hematoma: focal, with clinical history
Differential Diagnosis
| Cause | Distribution | Enhancement | Key Distinguishing Feature |
|---|---|---|---|
| Inflammatory breast cancer | Diffuse | Diffuse dermal enhancement | Rapid onset, peau d’orange, often with underlying mass or NME |
| Radiation therapy | Diffuse (treated breast) | Variable, often minimal | History of RT, typically stable or slowly resolving |
| Post-surgical | Focal (near scar) | Minimal or absent | Correlates with surgical site, stable over time |
| Systemic edema (CHF/renal) | Bilateral, symmetric | None | Both breasts equally affected, clinical context |
| Mastitis | Focal or regional | Present (often intense) | Clinical signs: erythema, warmth, pain, fever |
| Lymphatic obstruction | Diffuse, unilateral | None to mild | Ipsilateral axillary pathology or prior dissection |
Clinical Significance
- In the absence of enhancement and particularly when stable on prior imaging, skin thickening alone is not suspicious and should not trigger biopsy
- Diffuse skin thickening with diffuse skin enhancement is the hallmark of inflammatory breast cancer (T4d)
- Skin thickening is a modifier of BI-RADS assessment — its significance depends entirely on clinical context and associated findings
- When new or progressive, skin thickening should prompt evaluation for an underlying malignancy even without a discrete mass
- Bilateral symmetric skin thickening almost always reflects a systemic rather than malignant etiology
Board Pearl
Skin thickening alone (without enhancement) is NOT the same as skin involvement. Skin thickening = morphologic change only; skin involvement = definitive enhancement within the skin = more suspicious. Always check for skin enhancement on post-contrast images before escalating the BI-RADS category.
Board Pearl
The inframammary fold and periareolar region are physiologically thicker — do not overcall normal skin in these locations as pathologic thickening. Always compare with the contralateral breast at the same anatomic level.
Board Pearl
New unilateral diffuse skin thickening + diffuse skin enhancement + breast edema in a patient with erythema = inflammatory breast cancer until proven otherwise. Skin punch biopsy (not core biopsy of breast parenchyma) is the diagnostic procedure to confirm dermal lymphatic invasion.
Pitfalls
- Overcalling physiologic thickening: Skin at the inframammary fold and nipple-areolar complex is normally > 2 mm — always compare with the contralateral side
- Confusing skin thickening with skin involvement: Thickening is morphologic; involvement requires enhancement — the distinction changes management
- Attributing bilateral thickening to malignancy: Bilateral symmetric skin thickening is almost always systemic (CHF, renal failure, fluid overload) — check the clinical history
- Ignoring progressive unilateral thickening: New or worsening unilateral skin thickening warrants further workup even without a mass
- Post-radiation false positive: Radiation-induced skin thickening can persist for years and may enhance — correlation with treatment history is essential to avoid unnecessary biopsy
- Measurement technique: Skin should be measured perpendicular to the skin surface on axial or sagittal images — oblique measurements artificially increase apparent thickness
Reporting Tips
- State whether thickening is focal or diffuse
- Note whether enhancement is present within the thickened skin
- Compare with prior studies to assess stability or progression
- Compare with the contralateral breast for asymmetry
- Note associated findings: edema, axillary lymphadenopathy, peau d’orange, underlying mass or NME
- If post-treatment, document the date of surgery or radiation